JOMPAC

Journal of Medicine and Palliative Care (JOMPAC) is an open access scientific journal with independent, unbiased, and double-blind review under international guidelines. The purpose of JOMPAC is to contribute to the literature by publishing articles on health sciences and medicine.

EndNote Style
Index
Original Article
Comparison of 99mTc-HMPAO-labeled leukocyte scintigraphy findings with systemic inflammatory markers
Aims: Technetium-99m-hexamethylpropylene amine oxime (99mTc-HMPAO) labeled leukocyte scintigraphy is frequently used for infection imaging. The systemic immune-inflammation index is a new marker. In this study, we aim to investigate the relationship between 99mTc-HMPAO-labeled leukocyte scintigraphy findings and systemic inflammatory markers such as Neutrophil/lymphocyte ratios (NLR) and Platelet lymphocyte ratio (PLR) and systemic immune-inflammation index (SII).
Methods: Patients who underwent 99mTc-HMPAO-labeled leukocyte scintigraphy between 2014 and 2020 due to suspected infection such as diabetic foot infection or prosthesis infection vs. in any part of the body were included in our study. In addition, a negative control group consisting of 19 normal subjects who had no leukocyte scintigraphy and had hemogram examination was added to the study. Cases with findings consistent with infection in labeled leukocyte scintigraphy and infectious symptoms in this area of involvement in the clinical examination were considered as the positive group. The data were evaluated with the SPSS 23.0 program.
Results: Our study included 36 patients (28 males,8 females, mean age: 59.7). The mean SII was 1526±787 x109 cells/L in patients with positive findings in leukocyte scintigraphy that might be compatible with infection, while it was 1025 ± 370 x109 cells/L in patients who did not (p=0.017). The mean PLR was 183.95±68.30 in patients with positive findings in leukocyte scintigraphy that might be compatible with infection, while it was 145.81±58.30 in patients who did not (p=0.102). The mean NLR was 4.82±1.91 in patients with positive findings on leukocyte scintigraphy that might be compatible with infection, while it was 4.15±1.40 in patients who did not (p=0.181). While the negative control group and the patients who were considered positive in leukocyte scintigraphy were compared; a statistically significant difference was found between SII, NLR and PLR values. When the relationship between SII was evaluated, the mean SII was 1526±787 x109 cells/L in patients with involvement that may be compatible with infection in leukocyte scintigraphy, while it was 762±224 x109 cells/L in the negative control group (p<0.05). While the relationship between PLR was evaluated, the mean PLR was 183.95±68.30 in patients with involvement that might be compatible with infection in leukocyte scintigraphy, while it was 100.67±26.18 in the negative control group (p<0.05). When the relationship between NLR was evaluated, the mean NLR was 4.82±1.91 in patients with involvement that might be compatible with infection in leukocyte scintigraphy, while it was 3.11±0.85 in the negative control group (p<0.05).
Conclusion: When labeled leukocyte scintigraphy and systemic inflammatory markers were compared, there was a statistically significant relationship between the presence of infection in scintigraphy and SII, but the relationship with NLR and PLR were not statistically significant. When the negative control group and the patients who were considered positive in leukocyte scintigraphy were compared; a statistically significant difference was found between SII, NLR and PLR values. For this reason, we think that SII, NLR and PLR may be useful markers for diagnosis confirmation in centers that can’t perform radiolabeled infection imaging.


1. Ziessman HA, O&rsquo;Malley JP, Thrall JH. (2013). Nuclear medicine:the requisites e-book. Elsevier Health Sciences.
2. Signore A, Jamar F, Israel O, Buscombe J, Martin-Comin J, LazzeriE. Clinical indications, image acquisition and data interpretationfor white blood cells and anti-granulocyte monoclonal antibodyscintigraphy: an EANM procedural guideline. Eur J Nucl MedMol Imaging. 2018;45(10):1816-1831. doi:10.1007/s00259-018-4052-x
3. Love C, Marwin SE, Tomas MB, et al. Diagnosing infection in thefailed joint replacement: a comparison of coincidence detection18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloidmarrow imaging. J Nucl Med. 2004;45(11):1864-1871.
4. Palestro CJ. Radionuclide imaging of osteomyelitis. Semin NuclMed. 2015;45(1):32-46. doi:10.1053/j.semnuclmed.2014.07.005
5. Datz FL. Indium-111-labeled leukocytes for the detection ofinfection: current status. Semin Nucl Med. 1994;24(2):92-109.
6. Yaylali O. The role of molecular imaging methods in orthopedicprosthetic infections/Ortopedik protez enfeksiyonlarindamolekuler g&ouml;r&uuml;nt&uuml;leme y&ouml;ntemlerinin rol&uuml;. Nuclear MedicineSeminars. Vol. 2. No. 2. Galenos Yayinevi Tic. Ltd., 2016.
7. Velasco &Aacute;, Rodr&iacute;guez-Revuelta J, Oli&eacute; E, et al. Neutrophil-to-lymphocyte ratio: a potential new peripheral biomarker ofsuicidal behavior. Eur Psychiatry. 2020;63(1):e14. doi:10.1192/j.eurpsy.2019.20
8. Sun H, Que J, Peng Y, et al. The neutrophil-lymphocyte ratio: apromising predictor of mortality in coronary care unit patients- a cohort study. Int Immunopharmacol. 2019;74:105692.doi:10.1016/j.intimp.2019.105692
9. Bilen MA, Martini DJ, Liu Y, et al. The prognostic and predictiveimpact of inflammatory biomarkers in patients who haveadvanced-stage cancer treated with immunotherapy. Cancer.2019;125(1):127-134. doi:10.1002/cncr.31778
10. Hu J, Zhou W, Zhou Z, Han J, Dong W. Elevated neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict post-stroke depression with acute ischemic stroke. Exp Ther Med.2020;19(4):2497-2504. doi:10.3892/etm.2020.8514
11. Huang G, Chen H, Wang Q, et al. High platelet-to-lymphocyteratio are associated with post-stroke depression. J Affect Disord.2019;246:105-111. doi:10.1016/j.jad.2018.12.012
12. Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammationindex predicts prognosis of patients after curative resection forhepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212-6222. doi:10.1158/1078-0432.CCR-14-0442
13. Tong YS, Tan J, Zhou XL, Song YQ, Song YJ. Systemic immune-inflammation index predicting chemoradiation resistance andpoor outcome in patients with stage III non-small cell lungcancer. J Transl Med. 2017;15(1):221. doi:10.1186/s12967-017-1326-1
14. Govaert GAM, Bosch P, IJpma FFA, et al. High diagnosticaccuracy of white blood cell scintigraphy for fracture relatedinfections: Results of a large retrospective single-center study.Injury. 2018;49(6):1085-1090. doi:10.1016/j.injury.2018.03.018
15. Granados U, Fuster D, Soriano A, et al. Cribado medianteangiogammagraf&iacute;a previo a la realizaci&oacute;n de gammagraf&iacute;a conleucocitos (99m)Tc-HMPAO en el diagn&oacute;stico de infecci&oacute;n depr&oacute;tesis articulares [Screening with angiographic images priorto (99m)Tc-HMPAO labelled leukocyte scintigraphy in thediagnosis of periprosthetic infection]. Rev Esp Med Nucl ImagenMol. 2015;34(4):219-224. doi:10.1016/j.remn.2014.10.003
16. Şener K, &Ccedil;akır A, Kılavuz H, Altuğ E, G&uuml;ven R. Diagnosticvalue of systemic immune inflammation index in acuteappendicitis. Rev Assoc Med Bras (1992). 2023;69(2):291-296.doi:10.1590/1806-9282.20221003
17. Ozer Balin S, Ozcan EC, Uğur K. A New Inflammatory Markerof Clinical and Diagnostic Importance in Diabetic FootInfection: Systemic Immune-Inflammation Index [publishedonline ahead of print, 2022 Oct 11]. Int J Low Extrem Wounds.2022;15347346221130817. doi:10.1177/15347346221130817
18. Wang RH, Wen WX, Jiang ZP, et al. The clinical value ofneutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR)and systemic inflammation response index (SIRI) for predictingthe occurrence and severity of pneumonia in patients withintracerebral hemorrhage. Front Immunol. 2023;14:1115031.Published 2023 Feb 13. doi:10.3389/fimmu.2023.1115031
19. Carpio-Orantes LD, Garc&iacute;a-M&eacute;ndez S, Hern&aacute;ndez-Hern&aacute;ndezSN. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyteratio and systemic immune-inflammation index in patientswith COVID-19-associated pneumonia. &Iacute;ndices neutr&oacute;filo/linfocito, plaqueta/linfocito e inmunidad/inflamaci&oacute;n sist&eacute;micaen pacientes con neumon&iacute;a por COVID-19. Gac Med Mex.2020;156(6):527-531. doi:10.24875/GMM.M21000480
20. Asik Z. The Role of the NLR and PLR in urinary tractinfection. Clin Lab. 2021;67(10):10.7754/Clin.Lab.2021.210133.doi:10.7754/Clin.Lab.2021.210133
21. Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic andpredictive role of NLR, d-NLR and PLR in COVID-19patients. Int Immunopharmacol. 2020;84:106504. doi:10.1016/j.intimp.2020.106504
Volume 4, Issue 4, 2023
Page : 329-335
_Footer